Topics and Expertise: Food and Drug Administration (FDA)

Plan B under review again by the FDA

In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy c

Antivirals and the avian flu

The 2005 potential avian flu pandemic caused a shortage of antiviral drugs, leading to concerns about access, efficacy, and distribution.

Industry data should be shared

The same level of legal scrutiny that applies to research funded by the US government should apply to research funded by industry, according to UCSF School of Pharmacy faculty member Lisa Bero, PhD, and co-authors of a study that appeared July

Pages